TITLE:
Identifying Gaps in Real-World Management of Diabetes in Nigeria: A Subset Analysis of Cross-Sectional Wave-7 Data from the International Diabetes Management Practices Study
AUTHORS:
Babatope A. Kolawole, Felicia A. Anumah, Chioma Unachukwu
KEYWORDS:
Diabetes, Management Gaps, Nigeria
JOURNAL NAME:
Journal of Diabetes Mellitus,
Vol.12 No.4,
November
30,
2022
ABSTRACT: Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in Nigeria. Methods: This cross-sectional phase of the seventh wave of International Diabetes Management Practices Study, conducted between 22nd August and 30th September 2016, included adults with T1DM or T2DM during a two-week recruitment period. Results: Of 304 people with T2DM, 187 received oral glucose lowering drugs (OGLDs) only; 88 received OGLDs + insulin; 27 received insulin only. Metformin + sulfonylureas (128/187; 68.45%) and premix only (76/115; 66.09%) were the most used OGLD and insulin regimens respectively. Of 77 people with TIDM, all received insulin; six (7.79%) received OGLDs. Insulin initiation was noted around five years after diabetes diagnosis in T2DM (diabetes duration: 8.69 + 7.16 years; duration of insulin treatment: 3.17 ± 4.49 years). Proportion of people achieving glycemic targets (HbA1c Conclusion: Early insulinization and subsidized healthcare can improve long-term diabetes outcomes in Nigeria.